Su, X. et al. Phase separation of signaling molecules promotes T cell receptor signal transduction. Science 352, 595–599 (2016).
Google Scholar
Li, M. & Yu, Y. Innate immune receptor clustering and its role in immune regulation. J. Cell Sci. 134, jcs249318 (2021).
Google Scholar
Velders, M. P. et al. The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas. Br. J. Cancer 78, 478–483 (1998).
Google Scholar
Majzner, R. G. et al. Tuning the antigen density requirement for CAR T-cell activity. Cancer Discov. 10, 702–723 (2020).
Google Scholar
Watanabe, K. et al. Target antigen density governs the efficacy of anti-CD20–CD28–CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells. J. Immunol. 194, 911–920 (2015).
Google Scholar
Qin, W., Cho, K. F., Cavanagh, P. E. & Ting, A. Y. Deciphering molecular interactions by proximity labeling. Nat. Methods 18, 133–143 (2021).
Google Scholar
Xiao, Q., McAtee, C. K. & Su, X. Phase separation in immune signalling. Nat. Rev. Immunol. 22, 188–199 (2022).
Google Scholar
Degn, S. E. & Tolar, P. Towards a unifying model for B-cell receptor triggering. Nat. Rev. Immunol. 25, 77–91 (2025).
Google Scholar
Manz, B. N., Jackson, B. L., Petit, R. S., Dustin, M. L. & Groves, J. T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters. Proc. Natl Acad. Sci. USA 108, 9089–9094 (2011).
Google Scholar
Dustin, M. L. & Groves, J. T. Receptor signaling clusters in the immune synapse. Annu. Rev. Biophys. 41, 543–556 (2012).
Google Scholar
Albelda, S. M. Tumor antigen heterogeneity: the “elephant in the room” of adoptive T-cell therapy for solid tumors. Cancer Immunol. Res. 8, 2 (2020).
Google Scholar
Ma, L. et al. Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity. Cell 186, 3148–3165 (2023).
Google Scholar
Nijhof, I. S. et al. Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab. Leukemia 29, 2039–2049 (2015).
Google Scholar
Heitzeneder, S. et al. GPC2–CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity. Cancer Cell 40, 53–69 (2022).
Google Scholar
Chew, H. Y. et al. Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies. Cell 180, 895–914 (2020).
Google Scholar
Zhang, A. Q. et al. Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR. Nat. Biomed. Eng. 7, 1113–1128 (2023).
Google Scholar
Park, A. K. et al. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci. Transl. Med. 12, eaaz1863 (2020).
Google Scholar
Han, S., Li, J. & Ting, A. Y. Proximity labeling: spatially resolved proteomic mapping for neurobiology. Curr. Opin. Neurobiol. 50, 17–23 (2018).
Google Scholar
Li, J. et al. Cell-surface proteomic profiling in the fly brain uncovers wiring regulators. Cell 180, 373–386 (2020).
Google Scholar
Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880–887 (2018)
Google Scholar
Geri, J. B. et al. Microenvironment mapping via Dexter energy transfer on immune cells. Science 367, 1091–1097 (2020).
Google Scholar
Wang, P. et al. Mapping spatial transcriptome with light-activated proximity-dependent RNA labeling. Nat. Chem. Biol. 15, 1110–1119 (2019).
Google Scholar
Lin, Z. et al. Multiscale photocatalytic proximity labeling reveals cell surface neighbors on and between cells. Science 385, eadl5763 (2024).
Google Scholar
Tay, N. E. S. et al. Targeted activation in localized protein environments via deep red photoredox catalysis. Nat. Chem. 15, 101–109 (2023).
Google Scholar
Zhu, H. et al. Tyrosinase-based proximity labeling in living cells and in vivo. J. Am. Chem. Soc. 146, 7515–7523 (2024).
Google Scholar
Buksh, B. F. et al. muMap-Red: proximity labeling by red light photocatalysis. J. Am. Chem. Soc. 144, 6154–6162 (2022).
Google Scholar
Li, X., Lovell, J. F., Yoon, J. & Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17, 657–674 (2020).
Google Scholar
Chao, Y. & Liu, Z. Biomaterials tools to modulate the tumour microenvironment in immunotherapy. Nat. Rev. Bioeng. 1, 125–138 (2023).
Google Scholar
Lee, D., Huntoon, K., Lux, J., Kim, B. Y. S. & Jiang, W. Engineering nanomaterial physical characteristics for cancer immunotherapy. Nat. Rev. Bioeng. 1, 499–517 (2023).
Google Scholar
Chen, J., Zhu, Y. & Kaskel, S. Porphyrin-based metal–organic frameworks for biomedical applications. Angew. Chem. Int. Ed. Engl. 60, 5010–5035 (2021).
Google Scholar
Wang, J. et al. Porphyrinic metal–organic framework PCN-224 nanoparticles for near-infrared-induced attenuation of aggregation and neurotoxicity of Alzheimer’s amyloid-β peptide. ACS Appl. Mater. Interfaces 10, 36615–36621 (2018).
Google Scholar
Giuntini, F. et al. Insight into ultrasound-mediated reactive oxygen species generation by various metal–porphyrin complexes. Free Radic. Biol. Med. 121, 190–201 (2018).
Google Scholar
Hananya, N., Ye, X., Koren, S. & Muir, T. W. A genetically encoded photoproximity labeling approach for mapping protein territories. Proc. Natl Acad. Sci. USA 120, e2219339120 (2023).
Google Scholar
Scaranti, M., Cojocaru, E., Banerjee, S. & Banerji, U. Exploiting the folate receptor α in oncology. Nat. Rev. Clin. Oncol. 17, 349–359 (2020).
Google Scholar
Morath, I. et al. Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer. Oncogene 37, 1472–1484 (2018).
Google Scholar
Heider, K. H., Kuthan, H., Stehle, G. & Munzert, G. CD44v6: a target for antibody-based cancer therapy. Cancer Immunol. Immunother. 53, 567–579 (2004).
Google Scholar
Alford, R. et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol. Imaging 8, 341–354 (2009).
Google Scholar
Erkes, D. A. & Selvan, S. R. Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity. J. Immunol. Res. 2014, 175265 (2014).
Google Scholar
Shokat, K. M. & Schultz, P. G. Redirecting the immune response: ligand-mediated immunogenicity. J. Am. Chem. Soc. 113, 1861–1862 (2002).
Google Scholar
Lu, Y. & Low, P. S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol. Immunother. 51, 153–162 (2002).
Google Scholar
Lillemeier, B. F. et al. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat. Immunol. 11, 90–96 (2010).
Google Scholar
Nimmerjahn, F. & Ravetch, J. V. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34–47 (2008).
Google Scholar
Vaughan, T. J. et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat. Biotechnol. 14, 309–314 (1996).
Google Scholar
Liao, K. W., Lo, Y. C. & Roffler, S. R. Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells. Gene Ther. 7, 339–347 (2000).
Google Scholar
Pfistershammer, K. et al. No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation. Eur. J. Immunol. 36, 1104–1113 (2006).
Chakraborty, A. K. & Weiss, A. Insights into the initiation of TCR signaling. Nat. Immunol. 15, 798–807 (2014).
Google Scholar
Polak, R., Zhang, E. T. & Kuo, C. J. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat. Rev. Cancer 24, 523–539 (2024).
Google Scholar
Voabil, P. et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nat. Med. 27, 1250–1261 (2021).
Google Scholar
Belmontes, B. et al. Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors. Sci. Transl. Med. 13, eabd1524 (2021).
Google Scholar
Godbersen-Palmer, C., Coupet, T. A., Grada, Z., Zhang, S. C. & Sentman, C. L. Toxicity induced by a bispecific T cell-redirecting protein is mediated by both T cells and myeloid cells in immunocompetent mice. J Immunol 204, 2973–2983 (2020).
Google Scholar
Oslund, R. C. et al. Detection of cell–cell interactions via photocatalytic cell tagging. Nat. Chem. Biol. 18, 850–858 (2022).
Google Scholar
Pasqual, G. et al. Monitoring T cell–dendritic cell interactions in vivo by intercellular enzymatic labelling. Nature 553, 496–500 (2018).
Google Scholar
Liu, Z. et al. Detecting tumor antigen-specific T cells via interaction-dependent fucosyl-biotinylation. Cell 183, 1117–1133 (2020).
Google Scholar
Seath, C. P. et al. Tracking chromatin state changes using nanoscale photo-proximity labelling. Nature 616, 574–580 (2023).
Google Scholar
Peri, A. et al. The landscape of T cell antigens for cancer immunotherapy. Nat. Cancer 4, 937–954 (2023).
Google Scholar
Garcia-Guerrero, E. et al. Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab. Leukemia 35, 201–214 (2021).
Google Scholar
Kim, M. S. et al. Redirection of genetically engineered CAR-T cells using bifunctional small molecules. J. Am. Chem. Soc. 137, 2832–2835 (2015).
Google Scholar
Lee, Y. G. et al. Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors. Cancer Res. 79, 387–396 (2019).
Google Scholar
Morgan, R. A. et al. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18, 843–851 (2010).
Google Scholar
Riechelmann, H. et al. Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol. 44, 823–829 (2008).
Google Scholar
Castellarin, M. et al. A rational mouse model to detect on-target, off-tumor CAR T cell toxicity. JCI Insight 5, 175265 (2020).
Google Scholar
Feng, D. et al. Construction of ultrastable porphyrin Zr metal–organic frameworks through linker elimination. J. Am. Chem. Soc. 135, 17105–17110 (2013).
Google Scholar
Chen, X. et al. Formulation of metal–organic framework-based drug carriers by controlled coordination of methoxy PEG phosphate: boosting colloidal stability and redispersibility. J. Am. Chem. Soc. 143, 13557–13572 (2021).
Google Scholar
Lee, H., Dellatore, S. M., Miller, W. M. & Messersmith, P. B. Mussel-inspired surface chemistry for multifunctional coatings. Science 318, 426–430 (2007).
Google Scholar
Duan, H. et al. CD146 bound to LCK promotes T cell receptor signaling and antitumor immune responses in mice. J. Clin. Invest. https://doi.org/10.1172/JCI148568 (2021).
Su, S. et al. Immune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophages. Cell 175, 442–457 (2018).
Google Scholar
Neal, J. T. et al. Organoid modeling of the tumor immune microenvironment. Cell 175, 1972–1988 (2018).
Google Scholar
McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329–337 (2019).
Google Scholar
Wu, Y. PATCH v.1. Zenodo https://doi.org/10.5281/zenodo.16674296 (2025).